More Than a Decade of CML Experience at OHSU Knight Cancer Institute
For the past decade, hematologist/oncologist Dr. Michael Mauro has treated Chronic Myelogenous Leukemia (CML) patients at the OHSU Knight Cancer Institute and worked alongside Dr. Brian Druker on research that has made this a manageable disease for most patients. With rapid diagnostics, a "palette of clinical trials" and a team approach with community oncologists all at his fingertips, Dr. Mauro says it is a joy to see his patients in clinic, to offer them the best care possible and to see them living well with CML long term.
Experts & Guests
Michael Mauro, M.D.
Professor of Medicine, Division of Hematology and Medical Oncology, Oregon Health & Science UniversityDr. Michael Mauro is Professor of Medicine in the Division of Hematology and Medical Oncology at Oregon Health Science University. He received his medical degree from Dartmouth Medical School in New Hampshire and went on to complete his residency at New York Hospital-Cornell University Medical Center. Dr. Mauro’s clinical focus is leukemia, with a particular interest in CML. more >